Frailty
Human evidence and active trials are visible in this field
2,201 human-evidence records · 200 active trials · 248 visible funding records · 7,619 universities
Canadian Patent Publication
TREATMENT OF AGING FRAILTY COMPRISING ADMINISTERING BONE MARRIW DERIVED MESENCHYMAL STEM CELLS
Source-linked patent metadata for TREATMENT OF AGING FRAILTY COMPRISING ADMINISTERING BONE MARRIW DERIVED MESENCHYMAL STEM CELLS, including priority, record stage and longevity-topic connections.
Canadian publication snapshot
Application publication visible
This privacy-minimal view describes one official Canadian patent publication. It is not presented as a complete worldwide patent family.
- Representative publication
- CA3226181A1
- Earliest priority
- September 10, 2021
- Latest publication
- March 16, 2023
- Source record
- 1
- Patent offices
- 1
Patent-to-Evidence Translation Map
What is happening in the same scientific field?
These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.
Stem cells
Human evidence and active trials are visible in this field
51 human-evidence records · 17 active trials · 275 visible funding records · 5,850 universities
Why names are absent
This feed intentionally excludes party names and contact details to minimise personal data. Open the official record when a name is consequential.
Topics connected by metadata
Frailty88% metadata match
Stem cells88% metadata match
How the patent office classifies this invention
No patent classification is available in the retained record.
Verify in the original patent source →